Small Business Innovation Research · Small Business Technology Transfer

Zalgen Labs: SBIR & STTR awards

3 awards worth $2.80M to 1 companies since 2015 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).

Zalgen Labs's federal contracts and grants · All SBIR & STTR awards

Clear

Awards by year

YearPhase IPhase IIAmount
201810$796.1K
201510$2.00M

The latest year fills in over months: agencies report awards to SBIR.gov with a lag.

Latest matching awards

AwardCompanyAgencyPhaseAmountDate
Glycoprotein Immunoassay to Measure Protective Response to Lassa Vaccine · topic NIAIDZalgen Labs · MarylandDepartment of Health and Human Services · National Institutes of HealthSBIR Phase I$796.1K2018-03-16
Evaluation of fully human Pan-Old World Arenavirus monoclonal antibodies as candidate therapeutics for LCMV infection · topic NIAIDZalgen Labs · MarylandDepartment of Health and Human Services · National Institutes of HealthSBIR Phase I$147.7K2015-07-01
Late-stage development toward commercialization of multilineage point-of-care Lassa fever diagnostics · topic NIAIDZalgen Labs · MarylandDepartment of Health and Human Services · National Institutes of HealthSBIR Phase II – Direct to Phase II$1.86M2015-02-05

Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.